Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis-Reference-Cited by-同舟云学术

Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis

Published:2021-03-26 Issue:2 Volume:64 Page:156-162
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle & Nerve

Author:

Pham Nguyen Thanh Phuong¹²³⁴^ORCID,Leonard Charles E.³⁴⁵⁶,Bird Shawn J.⁷,Willis Allison W.¹²³⁴⁶,Hamedani Ali G.¹²³

Affiliation:

1. Department of Neurology University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

2. Translational Center for Excellence for Neuroepidemiology and Neurological Outcomes Research, Department of Neurology University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

3. Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology, and Informatics University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

4. Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

5. Center for Therapeutic Effectiveness Research, Department of Biostatistics, Epidemiology, and Informatics University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

6. Leonard Davis Institute of Health Economics, University of Pennsylvania Philadelphia Pennsylvania USA

7. Department of Neurology Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27230

Reference39 articles.

1. Generalized Myasthenia Gravis

2. Prulifloxacin as a trigger of myasthenia gravis

3. Emergency Department Management of a Myasthenia Gravis Patient with Community-Acquired Pneumonia: Does Initial Antibiotic Choice Lead to Cure or Crisis?

4. Myasthenia gravis and ciprofloxacin

5. POSSIBLE EXACERBATION OF MYASTHENIA GRAVIS BY CIPROFLOXACIN

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suspected Fluoroquinolone-Induced Exacerbation of Myasthenia Gravis in Dogs;Journal of the American Animal Hospital Association;2023-09-01

2. Fluoroquinolone-Associated Movement Disorder: A Literature Review;Medicines;2023-05-25

3. Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?;Pharmaceutics;2023-03-01

4. Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians;Open Forum Infectious Diseases;2022-06-15

5. The difficulty of confirming pharmacovigilance signals in myasthenia gravis;Muscle & Nerve;2022-04-07